TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
TherapeuticsMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.86−0.04 (-2.11%)
Close on Oct 19, 2026
- Market cap
- $21.66M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 9, 2022 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| May 6, 2022 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Oct 3, 2011 | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |
| Jul 27, 2009 | 3-for-1 | Earlier per-share figures divided by 3 |